Betahistine Dihydrochloride
Active peptic ulcer, bronchial asthma, pregnancy and lactation.
Meniere's disease, tinnitus and/or progressive loss of hearing, vertigo, dizziness.
Phaeochromocytoma. Porphyria.
N/A
Rash, pruritus, urticaria, dyspepsia, nausea, peptic ulcer disease, headache, dizziness, insomnia.
Betahistine improves the microcirculation in the labyrinth which reduces endolymphatic pressure.
May antagonise antihistamines. May decrease bronchodilator effects of beta-2 agonists.
N/A
Adult: Initially, 8-16 mg tid. Maintenance: 24-48 mg daily.
N/A
N/A
Should be taken with food.
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.